Additional Information

This is a research study for an investigational drug being developed for the treatment of certain types of cancer.

The purpose of this study is to look at how much of the study drug enters the circulation of the body when given as a tablet compared to a capsule formulation. The study will measure how much of the study drug gets into the blood and how long the body takes to get rid of it. The study will also evaluate the side effects of the study drug.

Labcorp Daytona Beach, FL is recruiting for:

- Healthy Non-Smoking Males and Females of Non-Childbearing Potential, age 18-65

- Body Mass Index between 18-32

- Study involves 1 stay of 12 nights, plus 1 follow-up call

- Compensation up to $4,881 may be provided for time and participation 

Details

Call Now to Schedule Your Screening Appointment! 

Check-in: Mar 13
Check-out: Mar 25

Follow up Visit: Mar 31

Additional Information

The study drug is an investigational drug being developed for the potential treatment of autoimmune diseases (a condition in which the immune system mistakenly attacks the body). 

The purposes of this study are to evaluate how much of the study drug enters the circulation of the body when given as a new test solution formulation of the study drug compared to the original reference solution formulation of the study drug after subcutaneous (under the skin) injections using a prefilled syringe. The safety and tolerability of the test formulation of the study drug compared to the reference formulation of the study drug.

The study drug will be given as two separate injections using a prefilled syringe by inserting a needle just under the surface of your skin. You will be randomly assigned to a dose group to receive injections either in both arms, both thighs, or both sides of the lower abdomen.

Labcorp Daytona Beach, FL is recruiting for:

- Healthy Adults, age 18-65

- Body Mass Index between 18-34

- Study involves 1 stay of 1 night, plus 11 follow-up visits and 3 phone calls

- Compensation up to $7,802 may be provided for time and participation

Details

Call Now to Schedule Your Screening Appointment! 

Group 7: 

Check-in: Feb 13
Check-out: Feb 14

Follow up Visits: Feb 16, 18, 21, 24, 28, Mar 7, 14, 28, Apr 11, 25, May 9

Phone Calls: Mar 21, Apr 4, 18

Additional Information

The investigational drug in this research study is being developed for the treatment of certain cancers. The purpose of this part of the study is to evaluate the new tablet formulation of the study drug with and without food.

Labcorp Daytona Beach, FL is recruiting for:

- Healthy Non-Smoking Men and Women of Non-Childbearing Potential, age 18-65

- Body Mass Index between 18-32

- Study involves 2 separate stays of 10 nights, plus 1 follow-up visit

- Compensation up to $10,305 may be provided for time and participation

- Receive up to $300 per qualified participant

Details

Call Now to Schedule Your Screening Appointment! 

Check-in: Mar 20
Check-out: Mar 30

Check-in: Apr 12
Check-out: Apr 22

Follow Up Visit: May 11

Additional Information

Labcorp Dallas, TX is recruiting for:

- Healthy Adults, age 18-60

- Body Mass Index between 18-32

- Study involves 1 stay of 3 nights, plus 1 follow-up visit

- Compensation up to $3,150 may be provided for time and participation

- Receive up to $250 per qualified participant

Details

The purpose of part A is to evaluate the safety and tolerability (side effects) of the study drug, how much of the study drug and its breakdown products get into the blood stream and urine and how long it takes the body to get rid of them. During your stay, you will be given a single, oral dose of the study drug or placebo (inactive drug) at increasing dose levels.

Depending on the group you are in, you will be dosing in a fasted or fed state.

Call Now to Schedule Your Screening Appointment!

Group A1a:

Check-in: March 7
Check-out: March 10

Follow up Visit: March 17

OR

Group A1b:

Check-in: March 8
Check-out: March 11

Follow up Visit: March 18

Additional Information

Labcorp Dallas, TX is recruiting for:

- Healthy Non-Smoking Males and Females of Non-Childbearing Potential, age 18-65

- Body Mass Index between 18-32

- Study involves 1 stay of 12 nights, plus 1 follow-up call

- Compensation up to $4,881 may be provided for time and participation

- Receive up to $200 per qualified participant

Details

The purpose of this study is to look at how much of the study drug enters the circulation of the body when given as a tablet compared to a capsule formulation. The study will also evaluate the effect food has on how much of the tablet form of the study drug gets into the bloodstream and how long it takes the body to get rid of it, and to collect information on any side effects that may occur when the tablet form of the study drug is taken with food and without food. The study will also assess the safety and tolerability (side effects) of the study drugs.

Call Now to Schedule Your Screening Appointment!

Group 1:

Check-in: March 6
Check-out: March 18

Follow up Call: March 24

OR

Group 3:

Check-in: March 20
Check-out: April 1

Follow up Call: April 7

Additional Information

The investigational drug being developed for the potential treatment of obesity. This is the first time the study drug will be given to humans. 

 The purpose of Part B is to evaluate safety, tolerability, how much of the study drug gets into the bloodstream and how long the body takes to get rid of it. The effect of the study drug on body weight and appetite following multiple doses will also be evaluated. 

Labcorp Daytona Beach is recruiting for:

- Healthy Overweight Adults, age 18-65

- Women must be of non-childbearing potential

- Body Mass Index between 27-40

- Study involves 12 separate stays totaling 19 nights and 6 follow-up visits

- Compensation up to $18,802 may be provided for time and participation

Details

Call Now to Schedule Your Screening Appointment!

Check-in: Apr 3
Check-out: Apr 8 

Check-in: Apr 11
Check-out: Apr 12

Check-in: Apr 18
Check-out: Apr 19

Check-in: Apr 25
Check-out: Apr 26

Check-in: May 2
Checkout: May 3

Check-in: May 9
Check-out: May 10

Check-in: May 16
Check-out: May 17

Check-in: May 23
Check-out: May 24

Check-in: May 30
Check-out: May 31

Check-in: Jun 6
Check-out: Jun 7

Check-in: Jun 13
Check-out: Jun 14

Check-in: Jun 20
Check-out: Jun 24

Follow up Visits: Jun 28, Jul 5, 19, Aug 2, 16 & 30   

Additional Information

Labcorp Dallas, TX is recruiting for:

- Healthy Overweight Adults, age 18-65

- Women must be of non-childbearing potential

- Body Mass Index between 27-40

- Study involves 12 separate stays totaling 19 nights and 6 follow-up visits

- Compensation up to $18,802 may be provided for time and participation

Details

Call Now to Schedule Your Screening Appointment!

Check-in: Apr 5
Check-out: Apr 10

Check-in: Apr 13
Check-out: Apr 14

Check-in: Apr 20
Check-out: Apr 21

Check-in: Apr 27
Check-out: Apr 28

Check-in: May 4
Checkout: May 5

Check-in: May 11
Check-out: May 12

Check-in: May 18
Check-out: May 19

Check-in: May 25
Check-out: May 26

Check-in: Jun 1
Check-out: Jun 2

Check-in: Jun 8
Check-out: Jun 9

Check-in: Jun 15
Check-out: Jun 16

Check-in: Jun 22
Check-out: Jun 26

Follow up Visits:  Jun, 30, Jul, 7, 21, Aug, 4, 18, Sep, 1 

Additional Information

Labcorp Dallas, TX is recruiting for:

- Healthy Non-Smoking Sterile Adults, age 18-65

- Body Mass Index between 18-32

- Study involves 2 separate stays totaling 40 nights, plus 3 follow-up visits

- Compensation up to $15,990 may be provided for time and participation

- Receive up to $400 per qualified participant

*Sterile Adults- Males with vasectomy or females of non-childbearing potential

Details

Call Now to Schedule Your Screening Appointment!

E4:

Check-in: Feb, 13, Mar 4,

Check-out: Feb 23, Apr 3

Follow up Visit: Feb 28, Apr 8, 11

Additional Information

Labcorp Dallas, TX is recruiting for:

- Healthy Adults, age 18-45

- Body Mass Index between 18-30

- Study involves 1 stay of 7 nights, plus 1 follow-up visit

- Compensation up to $5,970 may be provided for time and participation

- Receive up to $300 per qualified participant

Details

The purpose of Part A is to evaluate how much of the study drug gets into the bloodstream and urine, how long the body takes to get rid of it, and the safety and tolerability (side effects) of the study drug when given as a single dose. The effect the study drug has on how your heart pumps blood and its effect on heart rhythm will also be evaluated.

Call Now to Schedule Your Screening Appointment!

A3c:

Check-in: Mar 8

Check-out: Mar 15

Follow up Visit: Apr 7

A3d:

Check-in: Mar 13

Check-out: Mar 20

Follow up Visit: Apr 12

Additional Information

Labcorp Madison, WI is recruiting for:

- Healthy Adults, age 18-60

- Body Mass Index between 18-32

-Study involves 1 stay of 8 nights, plus 7 follow-up visits

- Compensation up to $10,328 may be provided for time and participation - Receive up to $300 per qualified participant

Details

Call now to schedule your appointment. 

3a

Check-in: Feb 12

Check-out: Feb 20

OPV: Feb 27, Mar 6, Mar 13, Mar 27, Apr 10, May 8, May 29

3b

Check-in: Feb 14

Check-out: Feb 22

OPV: Mar 1, Mar 8, Mar 15, Mar 29, Apr 12, May 10, May 31

Additional Information

The investigational drug in this research study is being developed for the treatment of breast cancer.

Labcorp Dallas, TX is recruiting for:

- Healthy Non-Smoking Males and Females of Non-Childbearing Potential, age 40-65

- Body Mass Index between 18-32

- Study involves 2 stays of 10 nights and 5 follow-up visits

- Compensation up to $11,744 may be provided for time and participation

- Receive up to $350 per qualified participant

Details

The purpose of Cohort 3 of this study is to measure how much of the study drug gets into the bloodstream, and how long it takes the body to get rid of it.

Group 3d:

Check-In: Feb 12, Mar 5

Check-Out: Feb 22, Mar 15

Outpatient Visit : Feb 27, Mar, 3, 20, 24, 27

OR

Group 3g:

Check-In: Feb 23, Mar 16

Check-Out: Mar 5, Mar 26

Outpatient Visit : Mar, 10, 14, 31, Apr 4, 7

Additional Information

This is a research study for an investigational drug being developed for the treatment of Duchenne muscular dystrophy, Becker muscular dystrophy, certain sub-types of limb-girdle muscular dystrophy, and metabolic myopathies.

This type of study is called a radiolabeled study. The study drug has been specially prepared to contain radiolabeled carbon [14C], a naturally occurring radioactive form of the element carbon. Adding a low dose of radiation to the study drug does not change how the drug works, but helps us to see how the drug appears in the blood, urine, and stool after it is given to you.

The purpose of Part B of this study is to measure how much of the study drug and its breakdown products get into the bloodstream, urine, and/or stool, and how long it takes the body to get rid of them. In addition, the safety and tolerability of the study drug will be evaluated. You will be given a single, oral dose (tablets) of the study drug followed two hours later by a single intravenous (IV) dose over 2 minutes.

Part B requires one in-clinic confinement of up to 9 days/8 nights. 

Labcorp Madison, WI is recruiting for:

- Healthy Males, age 18-55

- Body Mass Index between 18-32

- Study involves 1 stay of 8 nights

- Compensation up to $3,330 may be provided for time and participation

- Receive up to $200 per qualified participant

Details

Check-In: Feb 15, 2023

Check-Out: Feb 23, 2023

Additional Information

The study drug is a drug that has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with insomnia characterized by difficulties with sleep onset and/or sleep maintenance. The use of the study drug in this study is investigational.

The purpose of this study is to measure how much of the study drug gets into breast milk of healthy lactating women. In addition, the amount of exposure of the study drug to infants through breast milk will be estimated, and the safety and tolerability of the study drug in healthy lactating women will be evaluated.  You will receive a single, oral dose of the study drug. Breast milk will be collected from each breast using a personal electric pump approximately every 4 to 8 hours or as needed.  

You will be provided an electric breast pump in order to be able to pump milk which can be stored and which is available for the infant while you are participating in the study. Study staff will provide instructions on using the breast pump and storing the breast milk at home. During the study, your infant should be bottle-fed the stored breast milk. You may resume breastfeeding after the study.

Labcorp Madison, WI is recruiting for:

-Women ages 18+, currently breastfeeding their newborn

-Body Mass Index between 18-35

-Study involves 1 stay of 4 nights, plus 1 follow-up call

-Compensation up to $5,400 may be provided for time and participation

-Receive up to $500 per qualified participant

Details

Details: 

Check-In: January 29, 2023

Check-Out: February 2, 2023

Phone Call:February 7, 2023

Additional Information

Labcorp Madison is recruiting for:

- Healthy Overweight Adults, age 18-65

- Women must be of non-childbearing potential

- Body Mass Index between 27-40

- Study involves 12 separate stays totaling 19 nights and 6 follow-up visits

- Compensation up to $18,802 may be provided for time and participation

Details

Call Now to Schedule Your Screening Appointment!

Check-In: Feb 27    
Check-Out: Mar 4

Check-In : Mar 7
Check-Out: Mar 8      

Check-In: Mar 14    
Check-Out: Mar 15        

Check-In: Mar 21
Check-Out: Mar 22       

Check-In: Mar 28
Check-Out: Mar 29          

Check-In: Apr 4
Check-Out: Apr 5         

Check-In: Apr 11
Check-Out: Apr 12         

Check-In: Apr 18
Check-Out: Apr 19       

Check-In: Apr 25
Check-Out:Apr 26     

Check-In: May 2
Check-Out: May 3        

Check-In: May 9
Check-Out: May 10        

Check-In: May 16
Check-Out:May 20

Follow up Visit: May 24

Follow up Visit: May 31

Follow up Visit: Jun 14

Follow up Visit: Jun 28

Follow up Visit: Jul 12

Follow up Visit: Jul 26   

Additional Information

Labcorp Madison, WI is recruiting for:

- Healthy Overweight Males and Females, age 18-55.

- Females must be of non-childbearing potential.

- Body Mass Index between 30-39.9

- Study involves 1 stay of 6 nights and 2 follow-ups

- Compensation up to $3,697 may be provided for time and participation

- Receive up to $500 per qualified participant

Details

Details:

Check-In: Feb 20

Check-Out: Feb 26

Outpatient Visit: Feb 28

Outpatient Visit: Mar 2